George R. Gunn, Ph.D.
Affiliations: | 2001 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
ImmunologyGoogle:
"George Gunn"Parents
Sign in to add mentor| Yvonne Paterson | grad student | 2001 | Penn | |
| (Recombinant Listeria monocytogenes as a tumor therapeutic.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shealy DJ, Cai A, Staquet K, et al. (2010) Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α. Mabs. 2: 428-39 |
| Shi FF, Gunn GR, Snyder LA, et al. (2007) Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases. Vaccine. 25: 3338-46 |
| Snyder LA, Goletz TJ, Gunn GR, et al. (2006) A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice. Vaccine. 24: 3340-52 |
| Sewell DA, Shahabi V, Gunn GR, et al. (2004) Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7. Cancer Research. 64: 8821-5 |
| Gunn GR, Zubair A, Peters C, et al. (2001) Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. Journal of Immunology (Baltimore, Md. : 1950). 167: 6471-9 |
| Gunn GR, Peters C, Paterson Y. (2001) Listeriolysin--a useful cytolysin. Trends in Microbiology. 9: 161-2 |